Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
复制标题
DOI:
10.1038/s41379-020-0604-2
复制
发表时间:
2020-11
期刊:
影响因子:
--
通讯作者:
Hornick JL
中科院分区:
文献类型:
--
作者:
Papke DJ;Hung YP;Schaefer IM;Bredella MA;Charville GW;Reith JD;Fletcher CDM;Nielsen GP;Hornick JL
Chondroblastoma is currently classified as a benign neoplasm; however, chondroblastoma and chondroblastoma-like osteosarcoma have morphologic overlap, raising the possibility that some tumors diagnosed as chondroblastoma-like osteosarcoma might actually represent malignant chondroblastoma. The H3F3B K36M point mutation, which has not been reported in osteosarcoma, is identified in 95% of chondroblastomas and is reliably detectable by immunohistochemistry (IHC). We reviewed 11 tumors diagnosed as atypical chondroblastoma, malignant chondroblastoma, or chondroblastoma-like osteosarcoma (median follow-up: 8.8 years; range: 4 months–26.4 years). Seven chondroblastomas with cytologic atypia and permeative growth were designated “malignant chondroblastoma”; six were H3K36M-positive by IHC. Relative to conventional chondroblastoma, malignant chondroblastoma occurred in older individuals (median: 52 years; range: 29–57 years) and arose at unusual sites. Three of four tumors with long-term follow-up recurred, and one patient died of widespread metastases. One was found to have chromosomal copy number alter4ations and a SETD2 mutation in addition to H3F3B K36M. The four remaining tumors were classified as chondroblastoma-like osteosarcoma. Chondroblastoma-like osteosarcoma occurred in younger patients (median: 21 years; range: 19–40 years) than malignant chondroblastoma. In contrast to malignant chondroblastoma, all had regions of malignant cells forming bone. Two of three patients with long-term follow-up developed recurrences, and two died of disease, one with widespread metastases. No mutations in H3F3A/H3F3B were detected by Sanger sequencing. While malignant chondroblastoma and chondroblastoma-like osteosarcoma show significant morphologic overlap, they have distinct clinical presentations and genetic findings. When considering this challenging differential diagnosis, IHC using histone H3 mutation-specific antibodies is a critical diagnostic adjunct.
登录
查看更多内容
DOI:
10.1126/science.aac7272
发表时间:
2016-05-13
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Lu C;Jain SU;Hoelper D;Bechet D;Molden RC;Ran L;Murphy D;Venneti S;Hameed M;Pawel BR;Wunder JS;Dickson BC;Lundgren SM;Jani KS;De Jay N;Papillon-Cavanagh S;Andrulis IL;Sawyer SL;Grynspan D;Turcotte RE;Nadaf J;Fahiminiyah S;Muir TW;Majewski J;Thompson CB;Chi P;Garcia BA;Allis CD;Jabado N;Lewis PW
通讯作者:
Lewis PW
影响因子:
3.7
作者:
Saba, Karim H.;Cornmark, Louise;Nord, Karolin H.
通讯作者:
Nord, Karolin H.
影响因子:
3.4
作者:
Schaefer IM;Fletcher JA;Nielsen GP;Shih AR;Ferrone ML;Hornick JL;Qian X
通讯作者:
Qian X
影响因子:
6.4
作者:
Lu, Chuanyong;Ramirez, Daniel;Hameed, Meera
通讯作者:
Hameed, Meera
影响因子:
30.8
作者:
Behjati, Sam;Tarpey, Patrick S.;Presneau, Nadege;Scheipl, Susanne;Pillay, Nischalan;Van Loo, Peter;Wedge, David C.;Cooke, Susanna L.;Gundem, Gunes;Davies, Helen;Nik-Zainal, Serena;Martin, Sancha;McLaren, Stuart;Goodie, Victoria;Robinson, Ben;Butler, Adam;Teague, Jon W.;Halai, Dina;Khatri, Bhavisha;Myklebost, Ola;Baumhoer, Daniel;Jundt, Gernot;Hamoudi, Rifat;Tirabosco, Roberto;Amary, M. Fernanda;Futreal, P. Andrew;Stratton, Michael R.;Campbell, Peter J.;Flanagan, Adrienne M.
通讯作者:
Flanagan, Adrienne M.